Business
Covid: Oxford/AstraZeneca vaccine delivery to EU to be cut by 60% – The Guardian
Official says supply will be halved in first quarter of 2021 due to production problems
AstraZeneca is to cut deliveries of its Covid-19 vaccine to the EU by 60% in the first quarter of the year due to production problems, a senior official has told Reuters.
The jab it developed with the University of Oxford is already in widespread use in the UK, but the European Union has not yet approved it. It is expected to make a decision by 29 January.
AstraZeneca said in a statement to Agence-France Presse that if EU approval is granted, the initial volumes will be lower than anticipated.
The…
-
Noosa News22 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout
-
General22 hours agoMyanmar earthquake rescue efforts wind down as death toll hits 3,600
-
Noosa News23 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business22 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?